A surge of generics, biosimilars, and innovative therapies is expected in 2025, addressing conditions from cancer to chronic diseases, as outlined at the Academy of Managed Care Pharmacy annual ...

Linagliptin Medication Information Discover comprehensive details about Linagliptin, including its pronunciation, uses, dosage instructions, indications, and guidelines on how and when to take it ...

In November 2019, the two companies updated their partnership to focus specifically on the development and commercialisation of Jardiance, Trajenta (linagliptin), and Basaglar (insulin glargine).

The pharma industry's potential for sustained growth is reinforced by an aging population, escalating healthcare demands, and the increase in chronic diseases. Therefore, let’s assess the fundamentals ...

September 21, 2023, marked the sixth anniversary of the significant amendments to the Patented Medicines (Notice of Compliance) Regulations ...

New Delhi: The Union Health Ministry has mandated Barcode or Quick Response (QR) Code on the label of top 300 brands of drugs including Dolo, Allegra, Saridon, Corex effective August 1, 2023 to ...

This came after Boehringer Ingelheim, one of the world's leading, research-driven pharmaceutical companies, has obtained ad-interim injunctions against four domestic pharmaceutical companies that ...

German drug maker Boehringer Ingelheim (BI) on Tuesday said that it has obtained ad-interim injunctions against four domestic pharmaceutical companies - Eris Lifesciences, Emcure Pharma, Optimus ...

Multinational drug major Boehringer Ingelheim (BI) has obtained ad-interim injunctions against four domestic pharmaceutical companies -- Eris Lifesciences, Emcure Pharma, Optimus Pharma and MSN ...

Boehringer had launched a combination of two antidiabetic medicines: metformin and linagliptin in the Indian market under the brand name Trajenta/Trajenta Duo. The Court has restrained ...